Around the world, tremendous resources are being invested in prevention, diagnosis, and treatment of cancer. Cancer is the second leading cause of death in Europe and North America. Discovery and development of anticancer agents are the key focus of several pharmaceutical companies as well as non-profit government and non-government organizations, like the National Cancer Institute (NCI) in the United States, the European Organization for Research and Treatment of Cancer (EORTC), and the British Cancer Research Campaign (CRC). © 2009 Springer-Verlag New York.
CITATION STYLE
Narang, A. S., & Desai, D. S. (2009). Anticancer drug development: Unique aspects of pharmaceutical development. In Pharmaceutical Perspectives of Cancer Therapeutics (pp. 49–92). Springer US. https://doi.org/10.1007/978-1-4419-0131-6_2
Mendeley helps you to discover research relevant for your work.